Please login to the form below

Not currently logged in
Email:
Password:

Norton Healthcare

This page shows the latest Norton Healthcare news and features for those working in and with pharma, biotech and healthcare.

GSK accused of delaying generic Seroxat in UK

GSK accused of delaying generic Seroxat in UK

market. The OFT, which is the government department responsible for protecting consumers, said GSK infringed competition law by making “ substantial payments” to Alpharma, Generics (UK) and Norton Healthcare to delay plans ... These payments were

Latest news

  • NHS news in brief

    NHS news in brief. Our weekly round of NHS and healthcare stories. ... The companies have been named as: Kent Pharmaceuticals, Norton Healthcare, the Goldshield Group, Generics UK, Ranbaxy Laboratories UK Unit, and Regent-GM Laboratories.

  • Sandoz in fraud probe

    Six companies were named as part of the initial investigation: Generics UK, Kent Pharmaceuticals, Regent-GM Laboratories, Goldshield, Norton Healthcare and Ranbaxy (UK).

  • Nine drug executives to be charged in generics fraud probe

    At the time, other companies named by the SFO as being under investigation were Generics UK (a unit of Merck KGaA), Kent Pharmaceuticals, Regent-GM Laboratories, Norton Healthcare (a subsidiary of

  • AZ defiant after Symbicort patent revoked

    AZ defiant after Symbicort patent revoked. The European Patent Office has upheld an appeal by two generic drug manufactures, Norton Healthcare and Generics UK, and revoked a patent for Symbicort. ... The European Patent Office (EPO) has upheld an appeal

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...

Infographics